Home

J B Chemicals & Pharmaceuticals Ltd PE Ratio

Image

J B Chemicals & Pharmaceuticals Ltd

NSE: JBCHEPHARM

PE

39

Last updated on: Feb 22, 2025

Key Highlights

  • The P/E Ratio of J B Chemicals & Pharmaceuticals Ltd is 39 as of 22 Feb 15:30 PM .
  • The P/E Ratio of J B Chemicals & Pharmaceuticals Ltd changed from 14.4 on March 2020 to 46.3 on March 2024 . This represents a CAGR of 26.31% over 5 years.
  • The Latest Trading Price of J B Chemicals & Pharmaceuticals Ltd is ₹ 1605 as of 21 Feb 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of J B Chemicals & Pharmaceuticals Ltd

No data available

Company Fundamentals for J B Chemicals & Pharmaceuticals Ltd

Image

J B Chemicals & Pharmaceuticals Ltd

NSE: JBCHEPHARM

Share Price

₹ 1605.45

-25.00 (-1.53%)

stock direction

Last updated on: Feb 21, 2025

Market Price of J B Chemicals & Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring J B Chemicals & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 20251605.45
20 Feb 20251630.45
19 Feb 20251673.35
18 Feb 20251613.75
17 Feb 20251644.55
14 Feb 20251666.4
13 Feb 20251685.6
12 Feb 20251627.3
11 Feb 20251611.5
10 Feb 20251678.5

SWOT Analysis Of J B Chemicals & Pharmaceuticals Ltd

Strength

4

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for J B Chemicals & Pharmaceuticals Ltd

Asset Value vs Market Value of J B Chemicals & Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
J B Chemicals & Pharmaceuticals Ltd24981
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

PE Ratio of J B Chemicals & Pharmaceuticals Ltd Explained

24981

Market cap

640

Earnings

39.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of J B Chemicals & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of J B Chemicals & Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of J B Chemicals & Pharmaceuticals Ltd

No data available

* All values are in %

About J B Chemicals & Pharmaceuticals Ltd

  • J B Chemicals & Pharmaceuticals (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals in December 18th, 1976.
  • The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and APIs.
  • The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman.
  • The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95.
  • Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the company's sales.

J B Chemicals & Pharmaceuticals Ltd News Hub

J B Chemicals & Pharmaceuticals Ltd soars 1.09%, Gains for third straight session

J B Chemicals & Pharmaceuticals Ltd is up for a third straight session in a row. The stock is quotin

Read more

14 Aug 24

J B Chemicals & Pharmaceuticals allots 11,500 equity shares under ESOS

J B Chemicals & Pharmaceuticals has allotted 11,500 equity shares under ESOS on 08 August 2024. Cons

Read more

08 Aug 24

J B Chemicals & Pharmaceuticals consolidated net profit rises 24.25% in the June 2024 quarter

Net profit of J B Chemicals & Pharmaceuticals rose 24.25% to Rs 176.83 crore in the quarter ended Ju

Read more

08 Aug 24

J B Chemicals & Pharmaceuticals allots 69,850 equity shares under ESOS

J B Chemicals & Pharmaceuticals has allotted 69,850 equity shares under ESOS on 26 August 2024. Cons

Read more

27 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of J B Chemicals & Pharmaceuticals Ltd

What is the current PE Ratio of J B Chemicals & Pharmaceuticals Ltd?

The Current PE Ratio of J B Chemicals & Pharmaceuticals Ltd is 39.03 as on 22 Feb 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 22 Feb 2025.

What was the PE Ratio of J B Chemicals & Pharmaceuticals Ltd last year?

The PE Ratio of J B Chemicals & Pharmaceuticals Ltd was 37.21 last year, now the PE ratio is 39.03, showing a year-on-year growth of 4.9%.

What does the PE Ratio of J B Chemicals & Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of J B Chemicals & Pharmaceuticals Ltd is 39.03. This ratio indicates that investors are willing to pay 39.03 times the earnings per share for each share of J B Chemicals & Pharmaceuticals Ltd.

What is the PE Ratio Growth of J B Chemicals & Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of J B Chemicals & Pharmaceuticals Ltd grew by 4.9% whereas, the EPS ratio grew by -6.9.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions